Altria's Competitive Moats, Undervaluation, And Pivot Into Cannabis And Nicotine Make For A Compelling Buying OpportunitySeeking Alpha • 12/11/19
SA Interview: The Bear Case For Battleground Stock Altria With Blue Sky CapitalSeeking Alpha • 12/06/19
SA Interview: The Bull Case For Battleground Stock Altria With Atlas ResearchSeeking Alpha • 12/04/19
Tobacco stocks rise on report that FDA won't cut nicotine levels in cigarettes as plannedCNBC • 11/20/19